Riskpilot← Back to searchSign inGet full accessN2 Neuro Oy
OYDissolvedY-tunnus 2920515-7Pursimiehenkatu 2931-AMuu liikkeenjohdon konsultointi · NACE 70220Est. 2018— employees
Revenue 2023
EUR 0
EBITDA margin
—
+452% vs 2022
Equity ratio
—
Financial strength
Net profit 2023
EUR 2K
+269% vs 2022
| Revenue | EUR 0 | — |
| EBITDA | EUR 2K | +452% |
| Net profit | EUR 2K | +269% |
| Total assets | EUR 0 | -100% |
| Equity | EUR -5K | +24% |
| Employees | — | — |
Legal name
N2 Neuro Oy
Y-tunnus number
2920515-7
Legal form
Osakeyhtiö
NACE code
70220 · Muu liikkeenjohdon konsultointi
Founded
8. kesäkuuta 2018
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2023-11-30
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Muu liikkeenjohdon konsultointi
Address
Pursimiehenkatu 2931-A
Phone
+358207912510
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 23 | 232 | 84 | 1 | 0 |
| Staff expenses | — | −330 | −0 | −0 | −0 |
| EBITDA | 1 | 1 | −5 | −0 | 2 |
| Depreciation & amort. | — | — | — | — | −0 |
| EBIT | 1 | 1 | −5 | −0 | 2 |
| Net financials | −0 | −1 | −3 | −0 | −0 |
| Profit before tax | 1 | 0 | −8 | −1 | 2 |
| Tax | −0 | 0 | −0 | −0 | −0 |
| Net profit | 1 | −0 | −8 | −1 | 2 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 11 | 344 | 8 | 0 | 0 |
| Equity | 2 | 2 | −6 | −6 | −5 |
| Long-term debt | — | — | — | — | 2 |
| Short-term debt | 9 | 342 | 14 | 6 | 3 |
| Total debt | 9 | 342 | 14 | 6 | 5 |
EBITDA margin
157100.0%
This company
15.8%
Market median
+994204% vs market
20192023
Equity ratio
-487900.0%
This company
38.2%
Market median
-1277325% vs market
20192023
Return on equity
156500.0%
This company
18.4%
Market median
+850443% vs market
20192023
Net profit margin
156500.0%
This company
8.1%
Market median
+1931999% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20192023
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-11-30
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TK Chief Executive Officer | Chief Executive Officer | 2020 |
LT Deputy Member | Deputy Member | 2023 |
| Former (2) | ||
JM Deputy Member | Deputy Member | 2018 – 2020 |
JR | Audit | 2018 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Chairperson | 2020 | |
| Former (2) | ||
| Board of Directors | 2020 – 2023 | |
| Board of Directors | 2020 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of N2 Neuro Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tommi Kristian Eklund | Chief Executive Officer | 0 companies |
| Jarno Mikael Varis | Deputy Member | 0 companies |
| Lauri Topias Kuorikoski | Deputy Member | 0 companies |
| Jari Rikhard Paloniemi | Audit | 0 companies |
| Erno Ilari Suodenjoki | Board of Directors | 0 companies |
| Markku Aleksi Nieminen | Board of Directors | 0 companies |
| Michael Eyal Ovitz | Board of Directors | 0 companies |
| Jussi Sakari Nurmio | Chairperson | 0 companies |